Tag: Enhertu
AstraZeneca: New positive data for Enhertu
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Roche: CE marking for a companion test from Enhertu
(CercleFinance.com) – Roche announced on Wednesday that it had obtained CE marking for a companion diagnostic test to identify patients with metastatic breast cancer with low HER2 expression eligible for…
AstraZeneca: Extended approval for Enhertu in the USA
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
AstraZeneca: approval extended for Enhertu in the USA
(CercleFinance.com) – AstraZeneca announced on Tuesday that American health authorities had approved Enhertu for the treatment of adults with solid tumors expressing the HER2 gene. The biopharmaceutical group specifies that…
AstraZeneca: CHMP recommends approval of Enhertu
(CercleFinance.com) – AstraZeneca announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Agency has recommended the approval of Enhertu (trastuzumab deruxtecan) as a monotherapy intended…
AstraZeneca: Two new innovative statutes for Enhertu
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
AstraZeneca: New approval for Enhertu in China
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
AstraZeneca: First approval in China for Enhertu
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
AstraZeneca: FDA extends Enhertu approval
AstraZeneca announced Friday that the US FDA had approved Enhertu, the antibody-conjugate it developed with Japanese Daiichi Sankyo, in the treatment of lung cancer. The biopharmaceutical group specifies that the…
AstraZeneca: Enhertu approval extended to the United States
(CercleFinance.com) – AstraZeneca announced on Monday that it had received the green light from the American Food and Drug Administration (FDA) for the marketing of its immunotherapy Enhertu in the…
AstraZeneca: New positive results for Enhertu
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
AstraZeneca: ‘priority review’ for Enhertu in the USA
(CercleFinance.com) – AstraZeneca and Daiichi Sankyo announce that the United States Food & Drug Administration has received the Supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) for the treatment…